Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00281242 · ClinicalTrials.gov registry record
Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease
A clinical trial of Pulmonary Disease, Chronic Obstructive and Lung Diseases, Obstructive, sponsored by University of Michigan.
- Completed
- Registry status
- 37
- Enrollment target
- 1
- Study location
NCT00281242 is a study of Pulmonary Disease, Chronic Obstructive and Lung Diseases, Obstructive that has completed, run by University of Michigan. The registered enrollment target is 37 participants, below the 1,044-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00281242, a study of Pulmonary Disease, Chronic Obstructive and Lung Diseases, Obstructive, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether there is a statistical association between changes in sputum serial levels of two cytokines, interleukin (IL)-17 and IL-6, during the treatment course of a severe acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and during the clinical course itself (i.e., rate of recovery or potential complicated course). AE-COPD is defined as an episode requiring emergency room (ER) evaluation.
Conditions Studied
Interventions
- OTHER blood draw
Study Locations (1)
Michigan
- University of Michigan at Ann Arbor - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2005-09 |
| Est. Completion | 2010-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00281242
The ClinicalTrials.gov registry entry for NCT00281242 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,044-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (96% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pulmonary Disease, Chronic Obstructive appearing as the primary indexed condition, and to 1 intervention - of which blood draw is the first listed.
NCT00281242 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00281242 about?
NCT00281242 is a clinical study titled "Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease". The purpose of this study is to determine whether there is a statistical association between changes in sputum serial levels of two cytokines, interleukin (IL)-17 and IL-6, during the treatment course of a severe acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and during the cl...
What is the current status of trial NCT00281242?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2005-09. Estimated completion is 2010-07.
What conditions does trial NCT00281242 study?
This clinical trial studies the following conditions: Pulmonary Disease, Chronic Obstructive, Lung Diseases, Obstructive.
What interventions are being tested in trial NCT00281242?
The interventions under investigation include: blood draw (OTHER).
Who is sponsoring clinical trial NCT00281242?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00281242 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Disease, Chronic Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
RECRUITING · Phase 3
-
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
RECRUITING · Phase 1
-
Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD
RECRUITING · NA
-
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
RECRUITING · Phase 3
-
Trial to Determine Effective Aspirin Dose in COPD
RECRUITING · Phase 3
-
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
RECRUITING · Phase 3
Explore more on PlainTrial
Pulmonary Disease, Chronic Obstructive
All registered trials for this condition
Lung Diseases, Obstructive
All registered trials for this condition
Michigan
All trials with a study site in Michigan
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.